期刊文献+

HPV16E7蛋白编码基因原核表达与鉴定 被引量:2

Prokaryotic Expression and Identification of Human Papillomavirus Type 16 E7 Protein Encoding Gene
暂未订购
导出
摘要 目的研究HPV16E7蛋白的生物学特性及其细胞转化机制,对HPV16E7蛋白原核表达质粒进行构建、表达和鉴定。方法以临床确诊的HPV16感染患者子宫颈细胞DNA为模板,采用PCR方法扩增HPV16E7基因,经BamH和Hind双酶切后插入相同酶切pET32a(+)载体,转化JM109感受态细胞,并进行阳性克隆筛选。经IPTG对重组质粒进行蛋白诱导表达,SDS-PAGE和Westernblot检测目标蛋白表达情况。结果成功构建了原核表达质粒pET32/E7,HPV16E7-TRX融合蛋白在BL21(DE3)菌株中高效表达,在1mmol/LIPTG、30℃诱导条件下融合蛋白表达量占菌体总蛋白的30%左右。结论pET32/E7原核表达质粒的构建、HPV16E7融合蛋白的表达为进一步深入研究HPV16E7蛋白的生物学特性及其致细胞转化的作用机制奠定了基础。 Objective To construct the prokaryotic expression plasmid pET32/E7 and express the human papillomavirus type 16 E7 protein in E. coll. Methods HPV16 E7 gene was amplified by PCR. The amplified E7 fragment was inserted into the plasmid pET32a (+) that was digested with BamH Ⅰ and Hind Ⅱ The recombinant plasmid pET32/E7 was transformed into E. coli JM109 which was selected with ampicillin. The positive clones containing recombinant plasmid pET32/E7 were verified by BamH Ⅰ and Xho Ⅰ digestion, and then sequenced. HPV16 ET-TRX recombinant protein expression in the E. coli BL21 (ED3) was identified by SDSPAGE and Western blot. Results The prokaryotic recombinant plasmid pET32/E7 was successfully constructed. The BL21 (DE3) transformed recombinant plasmid pET32/E7 had expressed HPV16 ET-TRX recombinant protein effectively. Under the conditions of 1 mmol/L IPTG and 30 ℃, the amount of HPV16 ET-TRX recombinant protein was about 30% of bacterial total proteins. Conclusion The construction of the prokaryotic recombinant plasmid pET32/E7 and the successful expression of the recombinant protein HPV16 E7-TRX would strongly promote the research of the biological properties and the transformational mechanism of the HPV16 E7 protein on the specific cells.
出处 《四川大学学报(医学版)》 CAS CSCD 北大核心 2006年第2期187-190,共4页 Journal of Sichuan University(Medical Sciences)
关键词 HPV16 原核表达 SDS—PAGE 免疫印迹 Human papillomavirus type 16(HPV16) Prokaryotic Expression SDS-PAGE Immunoblot
  • 相关文献

参考文献9

  • 1Hausen HZ. Virus in human cancer. Science,1991;254(4):1167-1173.
  • 2Luxton J, Shepherd P. Human papillomavirus antigens and T-cell recognition. Curr Opin Infect Dis,2001;14(2):139-143.
  • 3金冬雁 黎孟枫.分子克隆实验指南(第2版)[M].北京:科学出版社,1995.343-371.
  • 4卞继峰,于修平.人乳头瘤病毒致癌机制的研究进展[J].中国病毒学,2004,19(5):531-534. 被引量:11
  • 5Psyrri A, Defilippis RA, Edwards APB, et al. Role of the retinoblastoma pathway in senescence triggered by repression of the human papillomavirus E7 protein in cervical carcinoma cells. Cancer Res,2004;64(9):3079-3086.
  • 6Nguyen DX, Westbrook TF, Mccance DJ. Human Papillomavirus type16 E7 maintains elevated levels of the cdc25A tyrosine phosphatase during deregulation of cell cycle arrest. Journal of Virol,2002;76(2):619-632.
  • 7Sheets EE, Urban RG, Crum CP,et al. Immunotherapy of human cervical high-grade cervical intraepithelial neoplasia with microparticale-delivered human papillomavirus 16 E7 plasmid DNA. Am J Obstet Gynecol,2003;188(4):916-926.
  • 8Cheng WF, Lee CN, Su YN, et al. Induction of human papillomavirus type 16-specific immunologic responses in a normal and an human papillomavirus-infected populations. Immunology,2005;115(1):136-147.
  • 9Youde SJ, Mccarthy CM, Thomas KJ, et al. Cross-typic specificity and immunotherapeutic potential of a human HPV16 E7-specific CTL line. Int J Cancer, 2005;114(4):606-613.

二级参考文献26

  • 1Fuja T J, Lin F, Osann K E, Bryant P J. Somatic mutations and altered expression of the candidate tumor suppressors CSNK1 epsilon,DLG1, and EDD/hHYD in mamumary ductal carcinoma[J]. Cancer Res, 2004, 64(3): 942-51.
  • 2Mazurek S, Zwerschke W, Jansen-Durr P, Eigenbrodt E. Effects of the human papillomavirus HPV-16 E7 oncoprotein on glycolysis and glutaminolysis: role of pyruvate kinase type M2 and the glycolyticenzyme complex[J]. Biochem J, 2001,356(1 ): 247-256.
  • 3Zhang X, Turnell A S, Gorbea C. et al. The targeting of the proteasomal regulatory subunit S2 by adenovirus E1A causes inhibition of proteasomal activity and increased p53 expression[J]. J Biol Chem, 2004, 31: [Epub ahead of print].
  • 4Wang Q, Griffin N, Southern S, et al. Functional analysis of the human papillomavirus type 16 El-E4 protein provides a mechanism for in vivo and in vitro keratin filament reorganization[J]. J Virol,2004,78(2): 821-33.
  • 5Finley D, Ciechanover A, Varshavsky A. Ubiquitin as a Central Cellular Regulator[J]. Cell, 2004, 116:29-32.
  • 6Waggoner S E. Cervical cancer[J]. The lancet, 2003, 361(9376):2217.
  • 7Singh L, Gao Q, Kumar A, et al. The high-risk human papillomavirus type 16 E6 counters the GAP function of E6TP1 toward small Rap G proteins[J]. J Virol, 2003, 77(2):1614-1620.
  • 8Zur H H. Papillomavirus and cervical cancer: from basic to clinical application[J]. Nat Rev Cancer, 2002,2(5):342.
  • 9Sitek B, Poschmann G, Schmidtke K, et al. Expression of MUPP1protein in mouse brain[J]. Brain Res, 2003, 970(1-2):178-87.
  • 10Ohashi M, Sakurai M, Higuchi M, et al. Human T-cell leukemia virus type 1 Tax oncoprotein induces and interacts with a multi-PDZdomain protein, MAGI-3[J]. Virology, 2004, 320(1):52-62.

共引文献23

同被引文献31

  • 1周启明,吴沛宏.T淋巴细胞亚群及NK细胞变化与原发性肝癌预后的关系[J].介入放射学杂志,2005,14(6):635-637. 被引量:11
  • 2刘风,徐玥璟.支原体肺炎患儿T淋巴细胞亚群和NK细胞水平的变化及其意义[J].实用临床医学(江西),2006,7(11):3-5. 被引量:17
  • 3方向明.β-防御素2研究进展[J].浙江大学学报(医学版),2006,35(6):581-584. 被引量:14
  • 4J·萨姆布鲁克 黄培堂 译.分子克隆实验指南(第3版)[M].北京:科学出版社,2002.492-499.
  • 5Luxton J, Shepherd P. Human papillomavirus antigens and T2 cell recognition. Curr Opin Infect Dis,2001;14(2):139-143.
  • 6Berglund P,Smerdou C,Fleeton MN, et al. Enhancing immune responses using suicidal DNA vaccines. Nat Biotech, 1998; 16 (6) : 562-565.
  • 7Leitner WW, Hwang LN, Deveer M J, et al. Alphavirus-based DNA vaccine breaks immunological tolerance by activating innate antiviral pathways. Nat Med,2003;9(1):33-39.
  • 8Leimer WW, Ying H, Driver DA, et al. Enhancement of tumor-specific immune response with plasmid DNA replicon vectors. Cancer Res, 2000 ; 60 (1) : 51-551.
  • 9Stoler MH. Human papillomaviruses and cervical neoplais:a model for carcinogenesis. Int J Gynecol Pathol, 2000 ; 19 (1) : 16-28.
  • 10Eguchi T, Takaki T, Itadani H, et al. Rb silencing compromises the DNA damage-induced G2/M checkpoint and causes deregulated expression of the ECT2 oncogene. Oncogene,2007;26(4):509-520.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部